Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
NCT07681713
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Friedreich's Ataxia
Interventions
DRUG:
Vatiquinone
Sponsor
PTC Therapeutics